| scholarly article | Q13442814 |
| P356 | DOI | 10.1006/GYNO.1995.1280 |
| P698 | PubMed publication ID | 7557599 |
| P2093 | author name string | Kim SJ | |
| Lee JM | |||
| Park JS | |||
| Kim JW | |||
| Namkoong SE | |||
| Bae SN | |||
| Han GT | |||
| Jung JK | |||
| P433 | issue | 1 | |
| P921 | main subject | cervix uterine cancer | Q160105 |
| chemotherapy | Q974135 | ||
| P304 | page(s) | 136-142 | |
| P577 | publication date | 1995-10-01 | |
| P1433 | published in | Gynecologic Oncology | Q5625182 |
| P1476 | title | Comparative study of the patients with locally advanced stages I and II cervical cancer treated by radical surgery with and without preoperative adjuvant chemotherapy | |
| P478 | volume | 59 |
| Q43634503 | A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma |
| Q43482203 | Adenocarcinoma of the cervix uteri: a retrospective study of 83 cases |
| Q60685446 | Chemotherapy in squamous cell carcinoma of the cervix uteri: Present role and perspectives |
| Q84528989 | Clinical effects of irinotecan hydrochloride in combination with cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer |
| Q36183224 | Clinical efficacy and safety of paclitaxel plus carboplatin as neoadjuvant chemotherapy prior to radical hysterectomy and pelvic lymphadenectomy for Stage IB2-IIB cervical cancer |
| Q46497740 | Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized study |
| Q37177784 | Comparative study of neoadjuvant chemotherapy before radical hysterectomy and radical surgery alone in stage IB2-IIA bulky cervical cancer |
| Q35362470 | Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? A large-scale retrospective study |
| Q33541958 | Current developments in the treatment of newly diagnosed cervical cancer |
| Q37611446 | Experience in stage IB2 cervical cancer and review of treatment |
| Q86745233 | Feasibility and safety of carboplatin plus paclitaxel as neoadjuvant chemotherapy for locally advanced cervical cancer: a pilot study |
| Q43662821 | Identification of human papillomavirus types 16 and 18 deoxyribonucleic acid sequences in bulky cervical cancer after chemotherapy |
| Q53353626 | Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. |
| Q81702066 | Management strategies for stage IB2 cervical cancer: a cost-effectiveness analysis |
| Q42939261 | Matched-case comparison for the efficacy of neoadjuvant chemotherapy before surgery in FIGO stage IB1-IIA cervical cancer |
| Q34364778 | Neoadjuvant chemotherapy in gynecologic oncology |
| Q50926459 | Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer. |
| Q46336860 | Neoadjuvant cisplatin and etoposide followed by radical hysterectomy for stage 1B-2B cervical cancer |
| Q33366042 | Neoadjuvant gemcitabine and cisplatin followed by radical surgery in (bulky) squamous cell carcinoma of cervix stage IB2. |
| Q38059316 | Prognostic value of responsiveness of neoadjuvant chemotherapy before surgery for patients with stage IB(2)/IIA(2) cervical cancer |
| Q37199926 | Promising treatment results of adjuvant chemotherapy following radical hysterectomy for intermediate risk stage 1B cervical cancer |
| Q27851395 | XRCC1 R399Q polymorphism is associated with response to platinum-based neoadjuvant chemotherapy in bulky cervical cancer |
Search more.